Hospital General Universitario de Elche -ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2019

  1. A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer

    Frontiers in Oncology, Vol. 9, Núm. APR

2017

  1. A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 616-624

2013

  1. Bevacizumab in advanced breast cancer: A new model for the assessment of activity in non-first-line treatment regimens

    Anti-Cancer Drugs, Vol. 24, Núm. 9, pp. 975-979

2010

  1. Editorial: Whither thou goest pain?

    Revista de la Sociedad Espanola del Dolor, Vol. 17, Núm. 4, pp. 187-189